2020 Biolabs Inc (AIDX)

Currency in USD
1.79
+0.07(+4.08%)
Closed·
1.77-0.02(-1.39%)
·
AIDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.681.85
52 wk Range
1.5150.00
Key Statistics
Prev. Close
1.79
Open
1.79
Day's Range
1.68-1.85
52 wk Range
1.51-50
Volume
101.69K
Average Volume (3m)
297.67K
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AIDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

2020 Biolabs Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

Compare AIDX to Peers and Sector

Metrics to compare
AIDX
Peers
Sector
Relationship
P/E Ratio
−5.0x−3.6x−0.5x
PEG Ratio
−0.14−0.010.00
Price/Book
−281.5x2.4x2.6x
Price / LTM Sales
9.1x1.9x3.2x
Upside (Analyst Target)
-57.9%45.2%
Fair Value Upside
Unlock15.4%6.4%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-0.26 / --
Revenue / Forecast
538.27K / --
EPS Revisions
Last 90 days

AIDX Income Statement

People Also Watch

4.02
BATL
-14.29%
0.895
AIXI
+7.83%
11.060
ONDS
+1.75%
4.1700
WNW
+1.96%
1.58
UCAR
+8.97%

FAQ

What Is the 2020 Biolabs (AIDX) Stock Price Today?

The 2020 Biolabs stock price today is 1.79 USD.

What Stock Exchange Does 2020 Biolabs Trade On?

2020 Biolabs is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for 2020 Biolabs?

The stock symbol for 2020 Biolabs is "AIDX."

What Is the 2020 Biolabs Market Cap?

As of today, 2020 Biolabs market cap is 18.69M USD.

What Is 2020 Biolabs's Earnings Per Share (TTM)?

The 2020 Biolabs EPS (TTM) is -0.76.

From a Technical Analysis Perspective, Is AIDX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has 2020 Biolabs Stock Split?

2020 Biolabs has split 0 times.

How Many Employees Does 2020 Biolabs Have?

2020 Biolabs has 19 employees.

What is the current trading status of 2020 Biolabs (AIDX)?

As of Apr 23, 2026, 2020 Biolabs (AIDX) is trading at a price of 1.79 USD, with a previous close of 1.79 USD. The stock has fluctuated within a day range of 1.68 USD to 1.85 USD, while its 52-week range spans from 1.51 USD to 50.00 USD.

What Is the AIDX After Hours Price?

AIDX's last after hours stock price is 1.77 USD, the stock has decreased by -0.02, or -1.39%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.